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Abstract
Human-animal chimeric embryos are embryos obtained by introducing human cells into
a non-human animal embryo. It is envisaged that the application of human-animal
chimeric embryos may make possible many useful research projects including producing
three-dimensional human organs in animals and verification of the pluripotency
of human ES cells or iPS cells in vivo. The use of human-animal chimeric
embryos, however, raises several ethical and moral concerns. The most
fundamental one is that human-animal chimeric embryos possess the potential
to develop into organisms containing human-derived tissue, which may lead to
infringing upon the identity of the human species, and thus impairing human
dignity. The Japanese Expert Panel on Bioethics in the Cabinet Office carefully
considered the scientific significance and ethical acceptability of the issue and
released its “Opinions regarding the handling of research using human-animal
chimeric embryos”. The Panel proposed a framework of case-by-case review, and
suggested that the following points must be carefully reviewed from the perspective of
ethical acceptability: (a) Types of animal embryos and types of animals receiving embryo
transfers, particularly in dealing with non-human primates; (b) Types of human cells and
organs intended for production, particularly in dealing with human nerve or germ cells;
and (c) Extent of the period required for post-transfer studies. The scientific knowledge
that can be gained from transfer into an animal uterus and from the production of an
individual must be clarified to avoid unnecessary generation of chimeric animals. The
time is ripe for the scientific community and governments to start discussing the ethical
issues for establishing a global consensus.
Keywords: ELSI, Human organ, Pluripotency, Embryonic stem cell (ESC), Induced
pluripotent stem cell (iPSC), Human dignity, Chimerization
Introduction
Human-animal chimeric embryos are created by introducing human cells into a non-
human animal embryo. One possible application of this research is the use of animals
to produce three-dimensional human organs in animals, which would produce animal
models of human diseases and supply human organs available for transplantation
(Rashid et al. 2014). Recent scientific progress may make such research a reality.
“Animal-Animal” chimeric embryos have been shown to develop into a target organ by
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using blastocyst complementation (Kobayashi et al. 2010; Matsunari et al. 2013).
Another application is the verification of pluripotency of human putative pluripotent
stem cells induced by molecular reprogramming. Although two phases of pluripotency
can be defined: naïve and primed (Nichols and Smith 2009), the regulatory principles
of pluripotency have not fully been elucidated (Hackett and Surani 2014). These
advances in resetting human pluripotent stem cells and demonstrating the subsequent
formation of interspecies chimeric embryos suggest that research in this field may
expand more rapidly than we currently imagine.
The use of human-animal chimeric embryos, however, raises several ethical and
moral concerns. The most fundamental one is that such embryos possess the potential
to develop into organisms containing human-derived tissue, which may lead to a blurring
of the identity of the human species. Human-animal chimeras, such as those generated
when transplanting human tumor cells into mice or creating a model mouse of the
human immune system (Hyun et al. 2007), have been used as important tools for biomed-
ical research. However, the use of human-animal chimeric embryos raises a serious ethical
concern because it is impossible to predict fully how human pluripotent stem cells will
develop in animal bodies. Such organisms could blur the boundary between human and
non-human organisms, if a significant number of human brain (nerve) or germ cells were
to function appropriately in animal bodies. Other concerns include the use of non-human
primates and procedures to ensure the welfare of animals used in such research. A careful
debate on the scientific significance and ethical acceptability of studies that involve
human-animal chimeric embryos is thus required.
Since 2012, the Japanese Expert Panel on Bioethics has discussed the ethical issues
regarding research that involves human-animal chimeric embryos, held hearings with
outside experts, and carried out surveys of research trends and regulations in other
countries. The panel is one of the expert panels under the Council for Science, Technology
and Innovation in the Cabinet Office; it investigates and deliberates on basic policies that
relate to ethical issues that arise from the rapid development of the life sciences; it consists
of medical doctors, journalists specialized in medical fields, as well as academic investigators
in stem cell research, law, and bioethics. The panel released its “Opinions regarding the
handling of research that involves human-animal chimeric embryos” in 2013 to state its
recommendations for revising the governmental guidelines. In light of the opinion, detailed
discussions are underway within the Ministry of Education, Culture, Sports, Science and
Technology (MEXT) for categorizing possible research projects involving human-animal
chimeric embryos.
In this paper, we describe scientific significance and ethical acceptability on research
that involve human-animal chimeric embryos—especially summary of discussion held by
the Japanese Expert Panel on Bioethics with regard to conditions for approving transfer
an human-animal chimeric embryo into an animal uterus. It is hoped that the debate in
Japan will be useful for the creation of research frameworks in other countries.
Guidelines and current status of relevant research
More than a decade ago, Japan established the framework on research that involves
human-animal chimeric embryos. In 2000, the Act on Regulation of Human Cloning
Techniques came into effect. In 2001, the Guidelines for Handling of a Specified
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Embryo were formulated on the basis of this law, which include the following stipula-
tions regarding human-animal chimeric embryos:
(1)They may only be produced for the purpose of basic research concerning “human
cell-derived organs transplantable to a human being”;
(2)They may only be cultured until the appearance of the primitive streak (maximum
14 days);
(3)For the time being, their transfer into a human or animal uterus is prohibited.
The prohibition on the transfer into a uterus is intended to prevent the production of
individuals in which the boundary between animal and human is blurred, and is based
on the Resolution of the Diet “The transfer of a human-animal chimeric embryo into a
human or animal uterus should be prohibited as long as there is the risk that it might
affect the preservation of human dignity in a manner equivalent to that of a human
clone or hybrid individual” (A Supplementary Resolution of the Diet of the Act on Regula-
tion of Human Cloning Techniques in 2000). These regulations are fundamentally based on
the objective of the Act: “to preserve human dignity, ensure the safety of each human life
and body, and maintain public order”.
Under the present guidelines in Japan, basic research is being conducted on producing
organs from human iPS cells. Nakauchi and colleagues have evaluated the chimera-
forming ability of human pluripotent stem cells in vitro (Masaki et al. 2015). Their cultur-
ing of human-animal chimeric embryos is permitted in vitro until the appearance of the
primitive streak, which precedes the start of tissue differentiation. If the aim is to produce
three-dimensional human organs and evaluate their function, however, it will be necessary
to transfer chimeric embryos into an animal uterus, culture them after the appearance of
the primitive streak (more than 14 days in total), and allow the organ to develop to a
certain size in vivo. These additional steps might raise ethical concerns of generating
human-animal chimeras.
Discussion held by the Japanese Expert Panel on Bioethics
Taking into account the ethical concerns and recent scientific progress described above,
the Panel considered the acceptable conditions for research that involves transferring
human-animal chimeric embryos into animal uterus, and proposed that:
(1)Measures be used to prevent the unnecessary generation of individual animals;
(2)If the generation of individuals is approved, there be no risk that the individuals
might develop into organisms that violate “human dignity” in the sense of infringing
upon the identity of the human species;
(3)Studies must possess both scientific significance and social acceptability”.
To prevent the generation of individuals that might infringe upon the identity of the
human species, it will therefore be necessary to explain scientifically that the individuals
will neither be human nor human-like organisms. It is thus important to ensure accuracy of
techniques for differentiating human stem cells into a specific tissue or organ in animals.
Regarding the precision of techniques to ensure that a human-animal chimeric embryo
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develops only into the target organ, much progress has been made since the guidelines were
formulated in 2001. Techniques to control differentiation, which involve animals genetically
lacking in specific organs, have been used to produce (1) rat pancreas in the bodies of
pancreatogenesis-disabled mice and vice versa (Kobayashi et al. 2010), as well as (2) pan-
creas derived from healthy pigs in pancreatogenesis-disabled pigs as a model of large live-
stock animals (Matsunari et al. 2013). In addition, cutting-edge genetic manipulation
techniques are used to induce differentiation selectively toward the endodermal lineage
(Kobayashi et al. 2015), and might be used to introduce suicide genes under neuron– or
germ cell–specific promoters to induce apoptosis of unwanted cells after differenti-
ation (Rashid et al. 2014). However, it is necessary to consider how to respond to
unintended events in the course of the research project in advance.
Irrespective of the accuracy of differentiation control techniques, however, limitations
should be imposed from the viewpoint of ethical acceptability. The Panel proposed that
the following points must be carefully considered to approve the transfer of a human-
animal chimeric embryo into an animal uterus:
(1)Types of animal embryos and types of animal recipients.
Studies of a non-human primate will require particular caution, both from the perspec-
tive of blurring the boundary between animals and humans and from the viewpoint of
animal welfare;
(2)Types of human cells used in chimeras or types of human cells and organs intended
for production.
In particular, producing a brain derived from human cells in an animal body may have
an effect on animal behavior, and should be regulated even at stages before individuals
are generated;
(3)Extent of the period required for research after transfer into an animal uterus.
The period will vary depending on matters including the study objective, type of animal
used, and organ to be produced. It will therefore be necessary to clarify what scientific
knowledge can be acquired in accordance with each individual study. When generating an
individual, the necessity of generating an individual should be considered upon clarifying
the scientific knowledge that can be obtained as well as the conditions for approving
transfer into an animal uterus.
When debating whether or not to permit the transfer of a human-animal chimeric
embryo to an animal uterus, the panel was aware that such transfer would comprise
the first step in numerous future research projects. It still remains unclear whether or
not human ES or iPS cells have the potential to form interspecies chimeras, and it is
unknown whether or not a human-animal chimeric embryo is even capable of undergoing
initial development in vivo. Injection of human pluripotent stem cells into mouse blasto-
cysts and in vitro culture did not result in human-mouse chimera formation (Masaki et al.
2015), whereas region-selective human pluripotent stem cells undergo interspecies chimeri-
zation ex vivo by using epiblasts isolated from mice (Wu et al. 2015). Given that highly
Mizuno et al. Life Sciences, Society and Policy  (2015) 11:15 Page 4 of 7
valuable research projects will likely be envisaged with advances in basic research, it will also
be necessary to engage a wider range of stakeholders, including patients and citizens, and to
discuss what kind of research is acceptable in society.
Establishing a regulatory framework in Japan
To situate the opinions of the Expert Panel within the regulatory framework in Japan, the
current guideline (Guidelines for Handling of Specified Embryos 2001), but not the act
(Act on Regulation of Human Cloning Techniques 2000), will need to be revised in terms
of the following points: (1) repealing the prohibition on transferring embryos into an ani-
mal uterus, and (2) establishing a framework for case-by-case review by stipulating un-
acceptable research purposes. The panel also pointed out that the use of human-animal
chimeric embryos may enable many useful research projects, and that the purposes of re-
search (limited under the current guidelines to basic research concerning the production
of human organs) should therefore be expanded. Because it is impossible to predict future
research developments with any certainty, the purposes of producing human-animal
chimeric embryos should not be limited too strictly by law or other regulations. Therefore,
the panel proposed a system whereby the regulatory framework indicates clearly
unacceptable research purposes (for example, generation of functional human brain in
non-human primates, and unnecessary generation of individual animals), and research
projects are approved on a case-by-case basis. The review process for basic research is
currently under the jurisdiction of MEXT. In addition, the Ministry of Health, Labour,
and Welfare will also be involved in the case of clinical studies in the future. Ensuring the
efficacy and safety needed to use organs/tissues derived from human-animal chimeric em-
bryos in clinical studies will require compliance with the “Act on the Safety of Regenera-
tive Medicine” and “The Pharmaceuticals, Medical Devices, and Other Therapeutic
Products Act” (Konomi et al. 2015). These laws and guidelines will constitute the legal
framework for research involving human-animal chimeric embryos, from basic research
to studies on the use of such embryos for medical purposes.
Current landscape of regulations in the UK, USA, and by the ISSCR
Research involving human-animal chimeric embryos has also been discussed in other
countries. In the United States, the National Institutes of Health released a set of guidelines
in 2009 (NIH 2009) based on the recommendations of the National Research Council and
the Institute of Medicine of the U.S. National Academies (2005). In the United Kingdom, a
report titled “Animals Containing Human Material (ACHM)” has been released (The
Academy of Medical Sciences 2011). The International Society for Stem Cell Research
(ISSCR) has also considered this issue and released a draft of its guidelines (ISSCR 2015).
These guidelines and reports provide important views that have not been addressed in the
Japanese opinion. With regard to the cells, tissues, or organs that may be produced, “the de-
gree” to which human nerve cells become functionally integrated in an animal’s central
nervous system (ISSCR 2015), and the “breeding” of animal chimeras that form human
gametes (NIH 2009; ISSCR 2015), are important factors for evaluating ethical concerns. This
implies that a complete prohibition of nerve- or germ-cell generation in animals might not
be necessary. The ACHM provides categories of human-animal chimeras whose production
should be restricted and points out the concern of altering “appearances” or behaviors that
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distinguish humans from other species (e.g., humanized skin, limb, or facial structure; Rashid
et al. 2014). With regard to the animal species used, transfer of human ES or iPS cells into
non-human primate blastocysts is prohibited in studies supported by the National Institutes
of Health (NIH 2009). With regard to transfer into an animal uterus, an embryo equivalent
to a human-animal chimeric embryo may be transferred into an animal uterus and allowed
to develop until halfway through the gestation period, with individual screening of research
projects as a prerequisite in the UK (Mizuho Information and Research Institute, Inc. 2013).
Japan has emphasized the importance of avoiding unnecessary generation of individual ani-
mals in the present opinions. Consequently, the scientific knowledge that can be gained in
accordance with each step of the experiment in vivo needs to be clarified to keep the cultur-
ing period as short as possible.
Human-animal chimeric embryos are presently dealt with inconsistently in differ-
ent countries, with no clear consensus on their prohibition or acceptance. The
time is ripe for the scientific community and governments to start discussing the
ethical issue.
Conclusion
(1)Looking at the current progress of research on human stem cells and human-animal
chimeric embryos, it may be possible to acquire new scientific knowledge on the
following matters with transfer human-animal chimeric embryos into an animal uterus.
(a)Confirmation of whether or not it is actually feasible to create organs from human
stem cells, whether or not they can be shaped, and whether or not they possess
the functions;
(b)Creation of novel animal models having human tissues/organs for elucidating the
pathologies of human disorders, including those that are currently intractable;
(c)Verification of the pluripotency of human putative pluripotent stem cells.
(2)Given that highly valuable applications will likely be envisaged with advances in research,
regulations on the research purpose should be capable of responding flexibly to the
advances in research. In addition to the “positive list” format of the current regulation
in Japan, which lists acceptable research purposes, it is appropriate to consider the
additional use of a “negative list” format that lists unacceptable research purposes, or a
shift to the negative list format completely. It is thus necessary to set up and operate a
framework for conducting a review for each study protocol. It is also necessary to
discuss what kind of research is acceptable in society.
(3)It is necessary to formulate conditions to ensure that there is no risk of violating human
dignity in the sense of infringing upon the identity of the human species. Irrespective of
the accuracy of differentiation control techniques, the following points must be carefully
considered from the viewpoint of ethical acceptability: types of animal embryos and
types of animals receiving embryo transfers; types of human cells used in chimeras or
types of human cells and organs intended for production; extent of the period required
for research after transfer into an animal uterus.
We consider the observations and recommendations by the Japanese Expert Panel on
Bioethics to be useful for the formulation of regulatory frameworks in other scientific
communities and governments.
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